Corton Capital’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$162K Buy
33,693
+8,113
+32% +$51.6K 0.4% 137
2025
Q2
$233K Buy
25,580
+9,385
+58% +$69.2K 0.27% 164
2025
Q1
$146K Buy
16,195
+1,065
+7% +$11.2K 0.48% 95
2024
Q4
$198K Sell
15,130
-2,728
-15% -$36.4K 0.11% 275
2024
Q3
$280K Buy
+17,858
New +$271K 0.14% 219
2024
Q2
Sell
-33,437
Closed -$927K 683
2024
Q1
$927K Sell
33,437
-3,879
-10% -$86.1K 0.34% 37
2023
Q4
$719K Buy
37,316
+17,168
+85% +$311K 0.23% 96
2023
Q3
$326K Sell
20,148
-386
-2% -$6.85K 0.16% 179
2023
Q2
$391K Buy
20,534
+8,447
+70% +$151K 0.18% 151
2023
Q1
$176K Sell
12,087
-210
-2% -$3.76K 0.12% 256
2022
Q4
$240K Buy
+12,297
New +$240K 0.2% 173
2022
Q3
Sell
-6,811
Closed -$214K 339
2022
Q2
$214K Sell
6,811
-1,988
-23% -$72K 0.2% 217
2022
Q1
$387K Sell
8,799
-5,682
-39% -$244K 0.17% 166
2021
Q4
$630K Buy
+14,481
New +$568K 0.28% 68

Other funds holding ACH

Corton Capital's ACH Position: Q3 2025 in Review

Corton Capital increased its Accendra Health (ACH) stake by 32% in Q3 2025, buying an estimated $51.6K and bringing the position to 33,693 shares worth $162K. The position accounts for 0.4% of the portfolio, ranked #137.

Corton Capital first reported a position in ACH in Q4 2021 and has held it in 14 quarters since. The position peaked at $927K in Q1 2024. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Corton Capital held 33,693 shares of Accendra Health worth $162K as of Q3 2025.
  • Corton Capital bought 8,113 Accendra Health shares in Q3 2025, an estimated $51.6K.
  • Accendra Health made up 0.4% of Corton Capital's portfolio in Q3 2025, its #137 holding.
  • Corton Capital first reported a position in Accendra Health in Q4 2021 and has held it in 14 quarters since.
  • Corton Capital's Accendra Health position peaked at $927K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.